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In studies of the induction of leukemia by inoculation of newborn mice with 
cell-free extracts of leukemic tissue from AK or AK_R strain mice, the observa- 
tion has been made repeatedly that a proportion of the recipient mice develop 
parotid tumors (1-9). 
The frequency of this  association  of parotid  tumor virus  (polyoma virus)  with 
mouse  leukemia  suggested  its possible  identity with  the leukemia  agent  reported 
by Gross (10), and, as a corollary, its possible etiologic role in lymphocytic leukemia 
of the AK strain. 
However, Gross has presented evidence  obtained from differential  centrifugation 
(11) and ether inactivation studies  (12) indicating  that the two agents are distinct. 
Also, tissue culture preparations of polyoma virus do not induce leukemia  (13), and 
spontaneous infection of laboratory mice with the agent shows no strain specificity 
(14), as must be postulated for a virus of AK leukemia. 
The finding of a moderate incidence of spontaneous  infection with polyoma virus 
in the breeding colony of one National Institutes of Health laboratory (14, 15) pro- 
vided an opportunity to apply epidemiologic procedures  to the problem of its relation 
to lymphocytic leukemia  occurring in various  strains of mice. 
Studies were made of the prevalence of antibody to polyoma virus in mice 
with and without spontaneous or x-ray-induced leukemia, and of the frequency 
of recovery of polyoma virus from leukemic tissues from AK mice with and 
without  antibody.  In  the  serologic experiments,  groups  of mice  expected to 
have a high incidence of leukemia were tested for hemagglutination-inhibiting 
(HI) antibody at a  time when some of the mice had developed leukemia; the 
animals  were placed under observation, and as individual animals  developed 
leukemia, they were retested; mice not developing leukemia were also retested, 
generally at a  later time than their leukemic cohorts. It was hoped that this 
procedure would provide both  cross-sectional and  longitudinal  survey data, 
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giving information on possible correlation of antibody with disease at a  single 
time period, as well as information on the relative risk of developing leukemia 
in mice with and without prior antibody. 
The virus isolation experiments were  carried out  primarily to  verify that 
HI antibody status of leukemic mice  had  the  same  significance with  regard 
to presence or absence of infection as had been determined previously for non- 
leukemic mice  (16).  For these  tests,  mice of the AKR strain were sacrificed 
when leukemic, the serologic status determined, and the tissues tested for the 
presence of virus. 
Materials and Methods 
Mice.--Tha high leukemic AKR/Lw and C58/Lw strains of mice were from our pedigreed 
colony and were kept in an animal room apart from experimental animals receiving inocula- 
tion of infectious materials; however, this room is adjacent to an animal room housing mice 
experimentally infected with polyoma virus. 
C3Hf/BiLw mice were housed in the latter animal  room;and consequently their potentiality 
for serologic  conversion was great (14). The inbred colony was started from 3 pedigreed litters 
of the F78 inbred  generation kindly supplied by Dr. J. J. Bittner.  They will be referred to 
hereafter, for convenience, as C3Hf/Bi strain mice. 
AKR/LwN mice were bred in the colonies of the NIH Animal Production Section, at the 
time under direction of Dr. G. E. Jay and Mr. S. M. Poiley. This strain, as well as all other 
strains in the Jay-Poiley colony, have been found to be free of polyoma virus infection as 
judged by absence of hemagglutination-inhibiting antibody (14, 15). Retired breeders were 
transferred to a semi-isolated room in our laboratories when they were 6~,~ to 8~ months old. 
The specific subline studied here was derived originally from our inbred AKR/Lw colony in 
July, 1956. Three litters of the F52 and F53 inbred generations formed the nucleus and these 
have been maintained separately from our colony since that time. 
Diagnosis of leukemia was made from histologic material. Fixation of non-antolyzed tissues 
was accomplished with Tellyesniczky's fluid, and staining with hematoxylin-eosin. 
Irradialion.--  C3Hf/Bi mice were irradiated once a week for 4 weeks beginning when the 
mice were 1 month of age. Physical factors for x-irradiation were as follows: Two opposing 
tubes above and below the mice were used, each 54 cm. from the mouse target; 200 kvp. 14 
ma. (each tube); beam filtration was 0.25 cm. Cu and 0.55 cm. Al; the radiation was delivered 
at 126.5 r/minute. 
Serologic Tests.--Diagnosis  of past infection with polyoma virus was based on tests  for 
hemagglutination-inhibiting (HI) antibody. Procedures for collection of serum and perform- 
ance of the HI tests have been described previously (14). Serums were tested as routine at 
dilutions of 1:100 and 1:200; serums giving no inhibition  at 1:100 were considered negative 
for antibody, and those inhibiting  hemagglutination to 1: 200 were considered positive. Serums 
inhibiting  at 1:100 but not at 1:200 were retested after treatment with receptor-destroying 
enzyme (RDE), and were considered positive if they inhibited at 1:100 after RDE treatment. 
The sensitivity and reliability of the HI test have been documented (14). 
Tests  for Viral Infectivity.--  Tests for virus in organs of leukemic mice were made by tissue 
culture and mouse  antibody production  (MAP) tests as already described (16). The spleen, 
liver, kidneys, lymph nodes, and parotid and submaxillary salivary glands of individual mice 
were ground in a mortar and suspended to 10 percent in Hanks' solution or medium 199. Each 
mouse in the MAP tests received 1.0 ml. of the supernatant fluid after settling, and each 
mouse embryo tissue culture  tube received 0.05 ml. of supernatant fluid after clarification L.  W.  LAW~  W,  P.  ROWE~  AND  J,  W.  HARTLEY  519 
by centrlfugatlon  at 2000 R.p.~a.  for I0 minutes. All suspensions were tested by the MAP 
procedure, and the  majority by tissue  culture  as  well;  as  in  the  tests  described  previously (16), 
the  results  obtained by  the  two procedures  were in  close  agreement, with the  MAP  test  some- 
what more sensitive. 
EXPERIMENTAL 
Spontaneous  Leukemia  in AKR M~e.--The relationship  of polyoma virus 
infection to spontaneous leukemia in AKR strain mice was studied in two colo- 
nies: mice reared in the infected colony (AKR/Lw mice), and mice of the same 
substrain  born  in  the uninfected Jay-Poiley colony  (AKR/LwN mice)  and 
transferred to the infected environment when approximately 6 to 8 months of 
age. 
As reported earlier (14), among a group of 41 high leukemia AKR/Lw strain 
mice,  constituting the F57  to F59  inbred generations,  tests for  complement 
fixing (CF) and HI antibody in mice 6 to 10 months of age revealed  positive 
serology in 4 of 24 leukemics (17 per cent) and 2 of 17 non-leukemics  (12 per 
cent). Eleven of the 17 non-leukemics developed lymphocytic leukemia in the 
following 1 to 2 months, including the two serologically positive animals,  and 
there was  no change  in antibody status of the late leukemic  animals when 
retested prior to death from the disease. These findings are summarized in line 
1 of Table I. 
Thirty-eight AKR/LwN mice from the Jay-Poiley colony were transferred 
to a semi-isolated room of our animal colony when 6~ to 8~ months of age. 
HI antibody tests were negative on all animals at this time and at retesting at 
7~,~ to 91/~ months of age. Of 31 which developed lymphocytic leukemia, pri- 
marily thymic in origin, after observation  until the age of 12  to 14 months, 
only 7 serological converters  were found (Table I, line 2). Two mice died non- 
leukemic  and HI-negative. Of the 5 remaining non-leukemics, 2 had become 
positive serologically when tested at 12 to 14 months while 3 remained negative. 
The incidence of 82 per cent lymphocytic  neoplasms in this group of AKR/LwN 
mice is similar to that observed in our AKR/Lw colony (17), from which this 
subline was derived, although the mean age at death from leukemia, 9.1 months, 
is somewhat longer than the 8.0 months recorded for our mice. A similar inci- 
dence of leukemia is reported by Gross in AK mice from his colony (18) among 
which an extremely high infection rate with polyoma virus has been found (14). 
Spontaneous  Leukemia  in  C58 Strain  Mice.--Cell-free leukemic extracts of 
spontaneous or  transplanted  C58  leukemics  have been  reported  to produce 
leukemia, parofid tumors, or soft tissue sarcomas when introduced into appro- 
priate recipient mice (19). Therefore,  the sera of uninoculated mice of the high 
leukemic C58/Lw inbred strain, generations F95 to 98, were tested for antibody 
to polyoma virus (Table I, line 3). Among 23 C58 mice examined initially  when 
7 to 10 months old, 8 were leukemic  (lymphocytic neoplasms) and only 1 of 
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In the following 4 months, 14 of these 15 became leukemic, at which time their 
antibody status was again determined. Only 2 of the 14 leukemics were found 
to be serologic converters, and these were litter mates. 
X-ray Induced Leukemia in C3tt Mice.--Thirty-five  C3Hf/Bi mice of the 
F85 to F87 inbred generations were given whole body, fractionated x-irradiation 
TABLE I 
Frequency of HI Antibody to Polyoma Virus in Leukemic and Non-Leukemic 





























0/37*  9.6 
0/15  10.1 
8/27  7.3 
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for antibody 
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9.2  0/6 
12.3  2/7 
(29%) 
12.0  0/1 





* All were  antibody-negative at  a  previous test when 6~,~ to  8~,~ months of age. 
:~ Sample of 10 mice were antibody-negative at  1  month of age prior to irradiation;  the 
remaining 25 of the original 35  mice in this group were antibody-negative at  2  months of 
age,  immediately after  the  last  irradiation. 
beginning at 1 month of age, as described in Materials and Methods. All were 
negative for antibody when tested prior to irradiation (10 mice) or at the end 
of the course of irradiation (25 mice). Six mice died from the bleeding procedure 
or irradiation, and were excluded from analysis. 
The earliest leukemias were seen at 5 months, in 2 mice. The entire group 
was retested for antibody at  this  time.  The 2  leukemic mice were negative, 
while 8 of the 27 non-leukemic mice had become positive. Among these 27 non- 
leukemic mice,  the  subsequent  incidence of leukemia  was  identical in  those 
with antibody (5 of 8, or 62 per cent), and those without antibody (12 of 19, 
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rate in the 19 antibody-negative mice was essentially the same in those which 
did and those which did not develop leukemia.  Thus, there was no evidence 
that the risk of developing  leukemia was influenced by prior polyoma virus 
infection either in the immediate or more distant past. 
The frequency of conversions  to serological  positives  among  this  x-rayed 
series is similar to that observed in our colony of non-irradiated C3Hf/Bi mice 
(14), in which the incidence of spontaneous neoplasms of reticular tissue  (in- 
cluding lymphocytic leukemia)  was found to be 21 per cent, appearing,  how- 
ever, between the llth and 18th months (20). 
Recovery of Virus from Leukemic Tissues.--The  data presented above indi- 
cated no association  between  development of leukemia  and serologic status. 
However, this approach did not eliminate the possibilities that leukemia might 
occur as a response to a polyoma virus infection so recent that insufficient time 
had elapsed for antibodies to develop,  or that leukemic mice could not form 
antibody in response to a recent infection. These two considerations were partic- 
ularly important in view of the fact that all mice studied here were housed in 
a  potentially contaminated environment. In either case, failure of antibody 
response should be reflected in presence of virus in the tissues of leukemic mice. 
To test this hypothesis, leukemic  tissues  from 32 AKR/Lw and AKR/LwN 
mice were tested for virus by the procedures described in Materials and Meth- 
ods. These mice were of a later group  than those recorded  in Table I. Of 21 
leukemic mice without antibody, only 2 (10 per cent) yielded virus,  whereas 6 
(55 per cent) of 11 leukemic mice with antibody were positive for virus. These 
results are in close agreement with virus isolation results reported previously 
for non-leukemic  mice from infected colonies (16); virus being detected in 2 
(8 per cent) of 24 serologically negative mice and from 15 (56 per cent) of 26 
serologically positive mice. 
These results indicate that AKR leukemia  is not a response to concurrent 
polyoma virus infection unaccompanied by antibody response, and also suggest 
that the recovery of virus is no more frequent from spontaneously leukemic 
than from non-leukemic mice from infected colonies. 
No parotid gland neoplasms were observed in any of the mice studied here. 
DISCUSSION 
Three  hypotheses may be  offered  to  explain  the  repeated  association  of 
polyoma virus and experimental  transmission  of leukemia of certain strains of 
mice:  (a)  the leukemias are caused by polyoma virus; (b) spontaneous or in- 
duced leukemia "activates" polyoma virus, or (c) the association is fortuitous. 
Three separate lines of evidence render the first of these hypotheses unten- 
able. The epidemiologic studies reported here indicate that there is no causal 
relationship between polyoma virus infection and development of leukemia in 
AKR, C58, and irradiated C3H mice. Also, the leukemogenic agent recovered 
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in its physical properties,  and is not neutralized by potent antiserum to poly- 
oma virus (21). 
"Activation" of polyoma virus by the leukemic process is also highly unlikely 
as an explanation of the association;  the virus recovery studies reported here 
indicate that polyoma virus was present in detectable form in normal mouse 
tissues as often as in leukemic mouse tissue. 
The concept that the association is fortuitous is supported by several obser- 
vations. In several instances, stock animals of laboratories from which induction 
of parotid tumors by leukemic filtrates has been reported have been shown to 
have a considerable frequency  of infection with polyoma virus (14); the chronic- 
ity of the virus carrier state with this agent makes it likely that polyoma virus 
would be present in a proportion of leukemic extracts, and also would be carried 
along in any serial passage of leukemic tissue or filtrates and in serial passage 
of other neoplasms  as well. Introduction of leukemic  extracts into newborn 
mice would serve to establish chronic infection with polyoma virus and to dis- 
seminate the agent throughout the colony. The diversity of laboratories  which 
have encountered polyoma virus in work with leukemic tissues can probably 
be explained by importation of mice from contaminated laboratories. 
SUMMARY 
The relationship of polyoma (parotid tumor) virus infection to spontaneous 
and x-ray induced lymphocytic neoplasms (leukemia) in mice has been studied 
in two sublines  of the high leukemic AKR strain, in the high leukemic  C58 
strain and in the x-ray responsive  C3Hf/Bi strain. There was found to be no 
correlation  of hemagglutination-inhibiting (HI)  antibody with leukemia  ap- 
pearing  at  various times  throughout life, and  there  was no evidence of in- 
creased risk  of developing leukemia  in  mice with prior antibody to polyoma 
virus.  Virus  isolation  experiments  accomplished  with  AKR  leukemic  mice 
showed that HI antibody status of these mice had the same significance with 
regard to presence or absence of detectable virus as was previously  observed 
for non-leukemic mice from infected colonies. 
The results of this study were interpreted as supporting the concept that the 
repeated association of polyoma virus and experimental  transmission of leuke- 
mia is fortuitous. 
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